Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

NCT00426855 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Bendamustine
DRUG: Bortezomib

Sponsor

Peter Moosmann

Collaborators

[object Object]